Literature DB >> 34339676

IMPACT OF VAX-A-MILLION LOTTERY ON COVID-19 VACCINATION RATES IN OHIO.

Neil K R Sehgal1.   

Abstract

BACKGROUND: A decrease in COVID-19 vaccination rates has led some states to consider various incentives to boost demand for vaccines. On May 13, 2021, Ohio announced a free weekly lottery for individuals who received at least one COVID-19 vaccination. This study seeks to rigorously quantify the impact of Ohio's vaccination lottery.
METHODS: A synthetic control consisting of a weighted combination of other states was used to approximate the demographic characteristics, new cases, and vaccination rates in Ohio prior to the lottery announcement. The difference in vaccination rates in Ohio and the synthetic control following the lottery announcement was then used to estimate the lottery's impact.
RESULTS: Prior to the lottery announcement, Ohio and synthetic Ohio had similar demographic characteristics and new case rates. Ohio and synthetic Ohio also had identical first vaccination rates. By the final lottery enrollment date of June 20, the percentage of the population with first vaccinations increased to 47.41% in Ohio and 46.43% in synthetic Ohio for a difference of 0.98% (95% confidence interval 0.42 to 1.54).
CONCLUSION: An additional 114,553 Ohioans received vaccinations as a result of the Vax-a-Million program (95% confidence interval [CI] 49,094 to 180,012) at a cost of approximately $49 per Ohioan vaccinated (95% CI $31 to $114). However, a majority of Ohioans remained unvaccinated by the end of the lottery indicating that additional efforts are needed to address barriers to vaccination. This synthetic control approach may also be useful to evaluate other COVID-19 incentive programs.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COVID-19; Incentive; Lottery; Synthetic Control Method; Vaccination

Year:  2021        PMID: 34339676      PMCID: PMC8323513          DOI: 10.1016/j.amjmed.2021.06.032

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


Various incentives have been proposed or implemented to increase coronavirus disease 2019 (COVID-19) vaccination. An additional 114,553 individuals received vaccinations as a result of Ohio's vaccine lottery at a cost of approximately $49 per Ohioan vaccinated. Health providers should continue to educate and encourage their patients to receive COVID-19 vaccinations. Alt-text: Unlabelled box

Introduction

A decrease in coronavirus disease 2019 (COVID-19) vaccination rates has led some states to consider various incentives to boost demand for vaccines. On May 13, 2021, Ohio Governor Mike DeWine announced a free weekly lottery called Vax-a-Million to be held every Wednesday from May 26 through June 23 for Ohioans who received at least 1 COVID-19 vaccination. The weekly prizes were $1 million for adults and college scholarships for children aged 12-17 years, totaling about $5.6 million over 5 weeks. By June 20, the end of the lottery enrollment period, nearly 3.5 million adults and 155,000 children had registered for the free lottery. Initial reports suggested that vaccinations increased substantially following DeWine's announcement, but later reports were more equivocal, and Ohio continues to trail the national average in vaccination rates. This study seeks to rigorously quantify the impact of Ohio's vaccination lottery. Doing so is important for several reasons. First, Ohio's lottery received a great deal of national and international attention. Second, governors of several other states mentioned Ohio's program in considering or launching similar programs. Third, federal officials cited Vax-a-Million in encouraging other states to develop their own incentives. Fourth, Ohio's was the first dedicated vaccine lottery and the deadline to enter has passed, so enough time has elapsed to examine its effect (ie, 38 days from May 13 to June 20).

Methods

A synthetic control was used to model vaccination rates in Ohio prior to the lottery announcement. This approach relies on the idea that a weighted combination of other states can better approximate the demographic characteristics, new cases, and vaccination rates in Ohio than any single state alone. Explanatory variables used to construct the synthetic control were selected based on past research identifying them as correlates of COVID-19 vaccination. , These variables include age, gender, race/ethnicity, education, poverty, and new case rates. Changes in vaccination rates in Ohio and synthetic Ohio following the lottery announcement can then be used as an indicator of the lottery's impact. As a result, the synthetic control approach combines elements of both matching and differences-in-differences techniques. National and state demographic data were obtained from the Census Bureau and COVID-19 case and vaccination rates from the Centers for Disease Control and Prevention.3, 4, 5 To account for lack of data updates on weekends by some states, all case and vaccination values represent 7-day rolling averages. All 30 days of case and vaccine data prior to the lottery announcement (April 13 through May 12, 2021) were used to create the synthetic control. The potential control pool consists of the other 49 states and the District of Columbia. Thirteen states implemented other cash lottery incentives (such as a ticket to a preexisting state lottery or a dedicated vaccine lottery) before June 20 and were excluded from the pool. The weights chosen for states in the synthetic control minimize root mean square prediction error in the period before the lottery announcement. The impact of the lottery on vaccination rates was assessed for the period from the lottery announcement date of May 13 to the final lottery enrollment date of June 20. Two sensitivity tests were performed to assess the robustness of the findings. First, an in-time placebo test reassigned the lottery announcement to the middle of the preannouncement period (April 28) with the final assessment occurring at the announcement date (May 13). Second, a leave-one-out test left out each of the selected control states one at a time. All analyses were conducted using the R package microsynth.

Results

The 11 states that contributed to the synthetic control and their weights are: Tennessee (0.211), North Dakota (0.161), Oklahoma (0.146), Nebraska (0.116), Wisconsin (0.109), Missouri (0.103), Utah (0.056), Michigan (0.039), Vermont (0.034), Alaska (0.032), and New Hampshire (0.004). Prior to the lottery announcement, Ohio and synthetic Ohio had similar demographic characteristics and new case rates (Table ). For example, the percentage of the population age 65 years or older was 17.5% in Ohio and 16.5% in synthetic Ohio. Ohio and synthetic Ohio also had identical first vaccination rates. On the day before the lottery announcement, 34.4% of the population in both regions had received at least 1 dose of a COVID-19 vaccine.
Table

Characteristics of Ohio and Synthetic Ohio Prior to Lottery Announcement

OhioSynthetic Ohio
Age ≥ 65 years, %17.516.5
Female, %51.050.8
White non-Hispanic, %78.477.2
College graduates, %28.329.7
Population below poverty level, %13.112.2
Daily new cases per 100,000 population
30 days before lottery announcement18.216.9
15 days before lottery announcement12.913.5
1 day before lottery announcement10.39.3
Received first vaccine dose, %
30 days before lottery announcement34.434.4
15 days before lottery announcement39.339.3
1 day before lottery announcement41.841.8
Characteristics of Ohio and Synthetic Ohio Prior to Lottery Announcement After the lottery announcement, there were increases in vaccination rates in both regions (Figure ). By June 20, the percentage of the population with first vaccinations increased to 47.41% in Ohio and 46.43% in synthetic Ohio for a difference of 0.98% (95% confidence interval [CI] 0.42-1.54). The in-time placebo sensitivity test did not suggest that factors other than the lottery were responsible for changes in observed vaccination rates. The leave-one-out sensitivity test indicated that results were not driven by any single control state.
Figure

Percentage of population that received first COVID-19 vaccine dose in Ohio and Synthetic Ohio from April 13, 2021 to June 20, 2021. COVID-19 = coronavirus disease 2019.

Percentage of population that received first COVID-19 vaccine dose in Ohio and Synthetic Ohio from April 13, 2021 to June 20, 2021. COVID-19 = coronavirus disease 2019.

Discussion

This analysis finds a statistically significant increase in first vaccinations in Ohio compared to a well-matched synthetic control. The difference is equivalent to 114,553 additional Ohioans getting vaccinated (95% CI 49,094-180,012) at a cost of approximately $49 per Ohioan vaccinated (95% CI $31-$114). However, a majority of Ohioans remained unvaccinated by the end of the lottery, indicating that additional efforts are needed to address barriers to vaccination. Limitations of this study include a focus on 1 state and adjustment for a small number of covariates. It is possible that lotteries or similar incentives in other regions may be more or less successful. The analyses do not account for smaller, nonlottery incentives adopted by some control states (such as free tickets to professional baseball games or amusement parks). As a result, the difference between Ohio and synthetic Ohio may be an underestimate. This study does not address ethical concerns associated with paying people to get vaccinated, nor does it assess potential long-term negative effects of incentives, such as engendering distrust in the safety of vaccines. These findings may be helpful to policy makers as they consider the merits and costs of similar lotteries. This synthetic control approach may also be useful to evaluate other COVID-19 incentive programs.
  2 in total

1.  Determinants of COVID-19 vaccine acceptance in the US.

Authors:  Amyn A Malik; SarahAnn M McFadden; Jad Elharake; Saad B Omer
Journal:  EClinicalMedicine       Date:  2020-08-12

2.  COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment.

Authors:  Jagdish Khubchandani; Sushil Sharma; James H Price; Michael J Wiblishauser; Manoj Sharma; Fern J Webb
Journal:  J Community Health       Date:  2021-01-03
  2 in total
  11 in total

1.  Institutional incentives for the evolution of committed cooperation: ensuring participation is as important as enhancing compliance.

Authors:  The Anh Han
Journal:  J R Soc Interface       Date:  2022-03-23       Impact factor: 4.118

Review 2.  Interventions to increase COVID-19 vaccine uptake: a scoping review.

Authors:  Marike Andreas; Claire Iannizzi; Emma Bohndorf; Ina Monsef; Vanessa Piechotta; Joerg J Meerpohl; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2022-08-03

3.  COVID-19 financial lottery effect on vaccine hesitant areas: Results from Ohio's Vax-a-million program.

Authors:  Peter J Mallow; Alec Enis; Matthew Wackler; Edmond A Hooker
Journal:  Am J Emerg Med       Date:  2021-08-26       Impact factor: 4.093

4.  Analysis of the Effectiveness of Measures on the COVID-19 Vaccination Rate in Hong Kong.

Authors:  Yui-Ki Chu; Pui-Hong Chung; Fei-Chau Pang
Journal:  Vaccines (Basel)       Date:  2022-05-10

5.  Between persuasion and compulsion: The case of COVID-19 vaccination in Canada.

Authors:  Eve Dubé; Dominique Gagnon; Noni MacDonald
Journal:  Vaccine       Date:  2022-05-25       Impact factor: 4.169

6.  Implementation of State Vaccine Incentive Lottery Programs and Uptake of COVID-19 Vaccinations in the United States.

Authors:  Binod Acharya; Chandra Dhakal
Journal:  JAMA Netw Open       Date:  2021-12-01

7.  Association between COVID-19 vaccination rates and the Australian 'Million Dollar Vax' competition: an observational study.

Authors:  Dajung Jun; Anthony Scott
Journal:  BMJ Open       Date:  2022-08-17       Impact factor: 3.006

8.  Associations between Bonus and Lottery COVID-19 Vaccine Incentive Policies and Increases in COVID-19 Vaccination Rates: A Social Epidemiologic Analysis.

Authors:  Yuqi Guo; Jingjing Gao; Omar T Sims
Journal:  Trop Med Infect Dis       Date:  2022-06-26

9.  Impact of incentives on COVID-19 vaccination; A systematic review.

Authors:  Parham Mardi; Shirin Djalalinia; Reza Kargar; Mahnaz Jamee; Zahra Esmaeili Abdar; Mostafa Qorbani
Journal:  Front Med (Lausanne)       Date:  2022-09-08

10.  Closing the Gap on COVID-19 Vaccinations in First Responders and Beyond: Increasing Trust.

Authors:  Megan E Gregory; Sarah R MacEwan; Alice A Gaughan; Laura J Rush; Jonathan R Powell; Jordan D Kurth; Eben Kenah; Ashish R Panchal; Ann Scheck McAlearney
Journal:  Int J Environ Res Public Health       Date:  2022-01-06       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.